Document:

Exhibit 10.6

 

IN8BIO, Inc.

RSU Award Grant Notice

(2020 Equity Incentive Plan)

 

IN8bio, Inc. (the “Company”)
has awarded to you (the “Participant”) the number of restricted stock units specified and on the terms
set forth below in consideration of your services (the “RSU Award”). Your RSU Award is subject to all
of the terms and conditions as set forth herein and in the Company’s 2020 Equity Incentive Plan (the “Plan”)
and the Award Agreement (the “Agreement”), which are incorporated herein in their entirety. Capitalized
terms not explicitly defined herein but defined in the Plan or the Agreement shall have the meanings set forth in the Plan or the
Agreement.

 

	Participant:	 	 	 
	 	 	 	 
	Date of Grant:	 	 	 
	 	 	 	 
	Vesting Commencement Date:	 	 	 
	 	 	 	 
	Number of Restricted Stock Units:	 	 	 

 

		Vesting Schedule:	[__________________________________________________________________]. 
	 	 	Notwithstanding the foregoing, vesting shall  terminate upon the Participant’s termination of Continuous Service.
	 	 	 
	 	Issuance Schedule:	One
share of Common Stock will be issued for each restricted stock unit which vests at the time set forth in Section 5 of the
Agreement.

 

Participant Acknowledgements: By
your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree
that:

 

		·	The RSU Award is governed by this RSU Award Grant Notice (the “Grant Notice”),
and the provisions of the Plan and the Agreement, all of which are made a part of this document. Unless otherwise provided in the
Plan, this Grant Notice and the Agreement (together, the “RSU Award Agreement”) may not be modified,
amended or revised except in a writing signed by you and a duly authorized officer of the Company.

 

		·	You have read and are familiar with the provisions of the Plan, the RSU Award Agreement and the
Prospectus. In the event of any conflict between the provisions in the RSU Award Agreement, or the Prospectus and the terms of
the Plan, the terms of the Plan shall control.

 

		·	The RSU Award Agreement sets forth the entire understanding between you and the Company regarding
the acquisition of Common Stock and supersedes all prior oral and written agreements, promises and/or representations on that subject
with the exception of: (i) other equity awards previously granted to you, and (ii) any written employment agreement,
offer letter, severance agreement, written severance plan or policy, or other written agreement between the Company and you in
each case that specifies the terms that should govern this RSU Award.

 

	IN8bio, Inc.	 	Participant:
	 	 	 	 	 
	By:	       	 	 
	 	Signature	 	 	Signature
	 	 	 	 	 
	Title:	 	 	Date:	    
	 	 	 	 	 
	Date:	 	 	 	 

 

    

     

    

 

IN8BIO, Inc.

2020
Equity Incentive Plan

 

Award
Agreement (RSU Award)

 

As reflected by your
Restricted Stock Unit Grant Notice (“Grant Notice”), IN8bio, Inc. (the “Company”)
has granted you a RSU Award under its 2020 Equity Incentive Plan (the “Plan”) for the number of restricted
stock units as indicated in your Grant Notice (the “RSU Award”). The terms of your RSU Award as specified
in this Award Agreement for your RSU Award (the “Agreement”) and the Grant Notice constitute your “RSU
Award Agreement”. Defined terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan
shall have the same definitions as in the Grant Notice or Plan, as applicable.

 

The general terms applicable
to your RSU Award are as follows:

 

1.            Governing
Plan Document. Your RSU Award is subject to all the provisions of the Plan. Your RSU Award is further subject to all
interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the
Plan. In the event of any conflict between the RSU Award Agreement and the provisions of the Plan, the provisions of the Plan shall
control.

 

2.            Grant
of the RSU Award. This RSU Award represents your right to be issued on a future date the number of shares of the Company’s
Common Stock that is equal to the number of restricted stock units indicated in the Grant Notice subject to your satisfaction of
the vesting conditions set forth therein (the “Restricted Stock Units”). Any additional Restricted Stock
Units that become subject to the RSU Award pursuant to Capitalization Adjustments as set forth in the Plan and the provisions of
Section 3 below, if any, shall be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions
on transferability, and time and manner of delivery as applicable to the other Restricted Stock Units covered by your RSU Award.

 

3.            Dividends.
You shall receive no benefit or adjustment to your RSU Award with respect to any cash dividend, stock dividend or other distribution
that does not result from a Capitalization Adjustment as provided in the Plan; provided, however, that this sentence shall not
apply with respect to any shares of Common Stock that are delivered to you in connection with your RSU Award after such shares
have been delivered to you.

 

4.            Withholding
Obligations.

 

(a)            Regardless
of any action taken by the Company or, if different, the Affiliate to which you provide Continuous Service (the “Service
Recipient”) with respect to any income tax, social insurance, payroll tax, fringe benefits tax, payment on account
or other tax-related items associated with the grant or vesting of the RSU Award or sale of the underlying Common Stock or other
tax-related items related to your participation in the Plan and legally applicable to you (the “Tax Liability”),
you hereby acknowledge and agree that the Tax Liability is your ultimate responsibility and may exceed the amount, if any, actually
withheld by the Company or the Service Recipient. You further acknowledge that the Company and the Service Recipient (i) make
no representations or undertakings regarding any Tax Liability in connection with any aspect of this RSU Award, including, but
not limited to, the grant or vesting of the RSU Award, the issuance of Common Stock pursuant to such vesting, the subsequent sale
of shares of Common Stock, and the payment of any dividends on the Common Stock; and (ii) do not commit to and are under no
obligation to structure the terms of the grant or any aspect of the RSU Award to reduce or eliminate your Tax Liability or achieve
a particular tax result. Further, if you are subject to Tax Liability in more than one jurisdiction, you acknowledge that the Company
and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax Liability
in more than one jurisdiction.

 

    1.

     

    

 

(b)            Prior
to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company
and/or the Service Recipient to satisfy all Tax Liability. As further provided in Section 8 of the Plan, you hereby authorize
the Company and any applicable Service Recipient to satisfy any applicable withholding obligations with regard to the Tax Liability
by any of the following means or by a combination of such means: (i) causing you to pay any portion of the Tax Liability in
cash or cash equivalent in a form acceptable to the Company; (ii) withholding from any compensation otherwise payable to you
by the Company or the Service Recipient; (iii) withholding shares of Common Stock from the shares of Common Stock issued or
otherwise issuable to you in connection with the Award; provided, however, that to the extent necessary to qualify for an
exemption from application of Section 16(b) of the Exchange Act, if applicable, such share withholding procedure will
be subject to the express prior approval of the Board or the Company’s Compensation Committee; (iv) permitting or requiring
you to enter into a “same day sale” commitment, if applicable, with a broker-dealer that is a member of the Financial
Industry Regulatory Authority (a “FINRA Dealer”), pursuant to this authorization and without further
consent, whereby you irrevocably elect to sell a portion of the shares of Common Stock to be delivered in connection with your
Restricted Stock Units to satisfy the Tax Liability and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary
to satisfy the Tax Liability directly to the Company or the Service Recipient; and/or (v) any other method determined by the
Company to be in compliance with Applicable Law. Furthermore, you agree to pay the Company or the Service Recipient any amount
the Company or the Service Recipient may be required to withhold, collect, or pay as a result of your participation in the Plan
or that cannot be satisfied by the means previously described. In the event it is determined that the amount of the Tax Liability
was greater than the amount withheld by the Company and/or the Service Recipient (as applicable), you agree to indemnify and hold
the Company and/or the Service Recipient (as applicable) harmless from any failure by the Company or the applicable Service Recipient
to withhold the proper amount.

 

(c)            The
Company may withhold or account for your Tax Liability by considering statutory withholding amounts or other withholding rates
applicable in your jurisdiction(s), including (i) maximum applicable rates in your jurisdiction(s), in which case you may
receive a refund of any over-withheld amount in cash (whether from applicable tax authorities or the Company) and you will have
no entitlement to the equivalent amount in Common Stock or (ii) minimum or such other applicable rates in your jurisdiction(s),
in which case you may be solely responsible for paying any additional Tax Liability to the applicable tax authorities or to the
Company and/or the Service Recipient. If the Tax Liability withholding obligation is satisfied by withholding shares of Common
Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common Stock subject to the vested portion
of the RSU Award, notwithstanding that a number of the shares of Common Stock is held back solely for the purpose of paying such
Tax Liability.

 

(d)            You
acknowledge that you may not participate in the Plan and the Company shall have no obligation to deliver shares of Common Stock
until you have fully satisfied the Tax Liability, as determined by the Company. Unless any withholding obligation for the Tax Liability
is satisfied, the Company shall have no obligation to deliver to you any Common Stock in respect of the RSU Award.

 

5.            Date
of Issuance.

 

(a)            The
issuance of shares in respect of the Restricted Stock Units is intended to comply with U.S. Treasury Regulations
Section 1.409A-1(b)(4) and will be construed and administered in such a manner. Subject to the satisfaction of the Tax
Liability withholding obligation, if any, in the event one or more Restricted Stock Units vests, the Company shall issue to
you one (1) share of Common Stock for each vested Restricted Stock Unit on the applicable vesting date. Each issuance
date determined by this paragraph is referred to as an “Original Issuance Date.”

 

(b)            If
the Original Issuance Date falls on a date that is not a business day, delivery shall instead occur on the next following business
day. In addition, if:

 

(i)            the
Original Issuance Date does not occur (1) during an “open window period” applicable to you, as determined by the
Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date when
you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including but not
limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange
Act and was entered into in compliance with the Company’s policies (a “10b5-1 Arrangement)), and

 

    2.

     

    

 

(ii)            either
(1) a Tax Liability withholding obligation does not apply, or (2) the Company decides, prior to the Original Issuance
Date, (A) not to satisfy the Tax Liability withholding obligation by withholding shares of Common Stock from the shares otherwise
due, on the Original Issuance Date, to you under this Award, and (B) not to permit you to enter into a “same day sale”
commitment with a broker-dealer (including but not limited to a commitment under a 10b5-1 Arrangement) and (C) not to permit
you to pay your Tax Liability in cash, then the shares that would otherwise be issued to you on the Original Issuance Date
will not be delivered on such Original Issuance Date and will instead be delivered on the first business day when you are not
prohibited from selling shares of the Common Stock in the open public market, but in no event later than December 31 of the
calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance
Date occurs), or, if and only if permitted in a manner that complies with U.S. Treasury Regulations Section 1.409A-1(b)(4),
no later than the date that is the 15th day of the third calendar month of the applicable year following the year in which the
shares of Common Stock under this Award are no longer subject to a “substantial risk of forfeiture” within the meaning
of U.S. Treasury Regulations Section 1.409A-1(d).

 

6.            Transferability.
Except as otherwise provided in the Plan, your RSU Award is not transferable, except by will or by the applicable laws of descent
and distribution

 

7.            Corporate
Transaction. Your RSU Award is subject to the terms of any agreement governing a Corporate Transaction involving the
Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act
on your behalf with respect to any escrow, indemnities and any contingent consideration.

 

8.            No
Liability for Taxes. As a condition to accepting the RSU Award, you hereby (a) agree to not make any claim against
the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from the RSU Award or
other Company compensation and (b) acknowledge that you were advised to consult with your own personal tax, financial and
other legal advisors regarding the tax consequences of the RSU Award and have either done so or knowingly and voluntarily declined
to do so.

 

9.            Severability.
If any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness
or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid.  Any
Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed
in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while
remaining lawful and valid.

 

10.          Other
Documents.  You hereby acknowledge receipt of or the right to receive a document providing the information
required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In addition,
you acknowledge receipt of the Company’s Trading Policy.

 

11.          Questions.
 If you have questions regarding these or any other terms and conditions applicable to your RSU Award, including a summary
of the applicable federal income tax consequences please see the Prospectus.

 

    3.Exhibit 10.16

 

 

 

AMENDED
AND RESTATED EMPLOYMENT AGREEMENT

 

This
Amended and Restated Employment Agreement (the “Agreement”) is entered into as of December 1, 2020
(the “Effective Date”), by and between William Ho (the “Executive”)
and IN8bio, Inc., its subsidiaries, parents, affiliates, predecessors, successors and assigns (together, the “Company”)
(Executive and the Company together, the “Parties”).

 

Recitals

 

WHEREAS, the Company
wishes to employ Executive and Executive wishes to be employed by the Company;

 

WHEREAS, the Company
and Executive desire to amend and restate the Employment Agreement, dated August 22, 2016, as amended by that certain Amendment
to Employment Agreement, dated November 6, 2019 (as amended, the “Prior Agreement”); and

 

WHEREAS, the Company
and Executive desire to enter into this Agreement to establish and govern the terms and conditions of Executive’s employment
by the Company.

 

NOW THEREFORE, in consideration
of the promises and mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:

 

Agreement

 

In consideration of
the foregoing, the parties agree as follows:

 

1.            Employment
by the Company.

 

1.1            Position;
Duties; Location. Subject to the terms and conditions of this Agreement, Executive shall
hold the position of President and Chief Executive Officer. Executive’s activities shall be as directed by the Company’s
Board of Directors (the “Board”) and shall include such duties and activities as typically associated
with Executive’s position, and as otherwise may be assigned to Executive from time to time. The Board may only change or
modify Executive’s title and/or duties with Executive’s written approval, which will not be unreasonably withheld.
Executive shall devote Executive’s business energies, interest, abilities and productive time to the proper and efficient
performance of Executive’s duties under this Agreement. Executive shall report to the Board and shall work primarily from
the Company’s New York City offices or remotely, as necessary, provided that the Company reserves the right to require business
travel.

 

1.2            Policies
and Procedures. The employment relationship between the parties shall be governed by
this Agreement and by the policies and practices established by the Board and provided to Executive. In the event that the terms
of this Agreement differ from or are in conflict with the Company’s policies or practices, this Agreement shall control.

 

     

     

    

 

1.3            Exclusive
Employment; Agreement not to Participate in Company’s Competitors. Except with
the prior written consent of the Board, Executive will not, during the period of employment by the Company, undertake or engage
in any other employment, or directly or indirectly, undertake or engage in any employment, directorships, occupation, or business
activity that competes with directly or indirectly, or is known by Executive to be adverse or antagonistic to the business, prospective
business, or financial or other interests of the Company, provided, however, that the Company agrees that Executive may continue
to serve in any roles, positions, and/or appointments listed in Exhibit A to this Agreement, or any similar roles, positions,
and/or appointments mutually agreed upon by the Company and the Executive, provided, in each case, they do not interfere with
Executive’s job duties for the Company.

 

1.4            Start
Date. Executive’s employment with the Company commenced on February 8, 2016.

 

2.             The
Employment Period.

 

Executive’s employment
relationship with the Company is, and shall at all times remain, at will. This means that either Executive or the Company may
terminate the employment relationship at any time, for any reason or for no reason, with or without cause or advance notice.

 

		3.	Compensation
                                         and Benefits.

 

3.1            Salary.
Beginning on December 1, 2020, Executive shall earn a base salary of $400,000 per
annum, less payroll deductions and all required withholdings (the “Base Salary”). The Company shall
increase the Base Salary to $500,000, following the pricing of an initial public offering of the Company’s common stock
and listing thereof on the Nasdaq Stock Market or New York Stock Exchange (or their constituent exchanges) (such event referred
to as the “IPO”). The Base Salary shall be prorated for any partial year of employment on the basis
of a 365-day year. The Base Salary shall be reviewed by the Board or the Compensation Committee of the Board, if applicable, no
less frequently than every 12 months during the Employment Period and may be increased at the discretion of the Board (but not
decreased without mutual agreement by Executive, which approval shall not be unreasonably withheld).

 

3.2            Performance
Bonus. Each calendar year, Executive will be eligible to earn a cash bonus of up to 40%
of Executive’s Base Salary based on the Board’s assessment of Executive’s individual performance and overall
Company performance (the “Annual Bonus”). Executive will draft individual and Company performance goals to
be approved by the Board annually upon which the Annual Bonus will be based. In addition, effective as of the date of the IPO,
Executive’s Annual Bonus eligibility shall increase to 50% of Executive’s Base Salary. In order to earn and receive
the Annual Bonus, Executive must remain employed by the Company through and including the bonus payout date, which will be on
or before March 15th of the year following the year to which it relates, unless otherwise provided in Section 5.
Executive shall be entitled to the Annual Bonus, or a percentage thereof, based on performance as set forth in the agreed upon
goals.

 

3.3            Stock
Options. Executive will be eligible to receive awards of stock options, restricted stock
or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time. The Board or a
committee of the Board shall determine in its discretion whether Executive shall be granted any such equity awards and the terms
of any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time.

 

     

     

    

 

3.4            Standard
Company Benefits. Executive shall, in accordance with Company policy and the terms of
the applicable plan documents, be eligible to participate in benefits under any benefit plan or arrangement that may be in effect
from time to time and made available to similarly situated Company employees. The Company reserves the right to modify, add or
eliminate benefits from time to time. Executive will also be eligible to accrue and use paid time off (“PTO”)
in accordance with the Company’s PTO policy.

 

3.5            Expense
Reimbursements. The Company will reimburse Executive for all reasonable business expenses
Executive incurs in conducting his duties hereunder, pursuant to the Company’s usual expense reimbursement practices.

 

3.6            Car
and Parking Allowance. The Company will reimburse Executive up to $1,800.00 for parking
and car-related payments monthly.

 

4.            Proprietary
Information Obligations. In connection with Executive’s employment with the Company,
Executive has received and had access to Company confidential information and trade secrets. Accordingly, Executive acknowledges
and agrees that Executive signed, was bound by, and abided by the terms of the Employee Confidential Information and Invention
Assignment Agreement, which Executive executed on August 22, 2016 (the “Prior CIIAA”). Notwithstanding,
in consideration of Executive’s continued access to confidential and trade secrets, Executive agrees to review the enclosed
Employee Confidential Information and Inventions Assignment Agreement and execute it on even date herewith (the “CIIAA”).

 

5.            Termination
of Employment; Severance.

 

5.1            At-Will
Employment. Executive’s employment relationship is at will. Either Executive or
the Company may terminate the employment relationship at any time, with or without cause or advance notice.

 

5.2            Executive’s
Resignation without Good Reason.

 

(a)            Executive
may resign from employment with Company without Good Reason.

 

(b)            If
Executive resigns from employment with the Company without Good Reason (as defined below), then, provided that Executive provides
at least thirty (30) days prior written notice (or such shorter prior written notice period agreed to in writing tby the Company),
the Company shall pay Executive, in addition to all earned but unpaid Base Salary accrued through the date of termination, all
accrued but unused PTO, at the rates then in effect, less standard deductions and withholdings, and all outstanding expenses.
Executive will no longer vest in any equity interests and the Company shall thereafter have no further obligations to Executive,
except as may otherwise be required by law or agreed to by the Company.

 

     

     

    

 

5.3            Termination
Without Cause; Resignation for Good Reason.

 

(a)            The
Company may terminate Executive’s employment with the Company at any time without Cause (as defined below). Further, Executive
may resign at any time for Good Reason (as defined below).

 

(b)            In
the event Executive’s employment with the Company is terminated by the Company without Cause, Executive resigns for Good
Reason then provided such termination constitutes a “separation from service” (as defined under Treasury Regulation
Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”),
and provided that Executive remains in compliance with the terms of this Agreement, subject to Section 5.7, Executive shall
receive the following:

 

(i)            The
Company shall pay Executive, in addition to all earned but unpaid Base Salary accrued through the date of termination, all accrued
but unused PTO, at the rates then in effect, less standard deductions and withholdings.

 

(ii)          The
Company shall pay Executive, as severance, eighteen (18) months of Executive’s base salary in effect as of the date of Executive’s
employment termination, subject to standard payroll deductions and withholdings (the “Severance”). The
Severance will be paid in equal installments on the Company’s regular payroll schedule over the eighteen (18) month period
following Executive’s Separation from Service; provided, however, that no payments will be made prior to the 60th
day following Executive’s Separation from Service. On the 60th day following Executive’s Separation from Service,
the Company will pay Executive in a lump sum the Severance that Executive would have received on or prior to such date under the
standard payroll schedule but for the delay while waiting for the 60th day in compliance with Code Section 409A,
with the balance of the Severance being paid as originally scheduled.

 

(iii)         [INTENTIONALLY
OMITTED]

 

(iv)          Provided
Executive timely elects continued coverage under COBRA, the Company shall pay Executive’s COBRA premiums to continue Executive’s
coverage (including coverage for eligible dependents, if applicable) (“COBRA Premiums”) through the
period (the “COBRA Premium Period”) starting on Executive’s Separation from Service and ending
on the earliest to occur of: (i) eighteen (18) months following Executive’s Separation from Service; (ii) the
date Executive becomes eligible for group health insurance coverage through a new employer; or (iii) the date Executive ceases
to be eligible for COBRA continuation coverage for any reason, including plan termination. In the event Executive becomes covered
under another employer's group health plan or otherwise cease to be eligible for COBRA during the COBRA Premium Period, Executive
must immediately notify the Company of such event. Notwithstanding the foregoing, if the Company determines, in its sole discretion,
that it cannot pay the COBRA Premiums without a substantial risk of violating applicable law (including, without limitation, Section 2716
of the Public Health Service Act), the Company instead shall pay to Executive, on the first day of each calendar month, a fully
taxable cash payment equal to the applicable COBRA premiums for that month (including premiums for Executive and Executive’s
eligible dependents who have elected and remain enrolled in such COBRA coverage), subject to applicable tax withholdings (such
amount, the “Special Cash Payment”), for the remainder of the COBRA Premium Period. Executive may, but
is not obligated to, use such Special Cash Payments toward the cost of COBRA premiums.

 

     

     

    

 

(v)           The
Company will accelerate the vesting of any equity interests granted to Executive, such that the shares that would have vested
in the eighteen (18) months following Executive’s Separation from Service shall be deemed vested as of Executive’s
last day of employment and Executive shall have up to ninety (90) days from Executive’s last day of employment within which
to exercise his vested options.

 

5.4            Termination
for Cause, Death, or Disability.

 

(a)            The
Company may terminate Executive’s employment with the Company at any time for Cause. Executive’s employment with the
Company may also be terminated due to Executive’s death or disability.

 

(b)            If
the Company terminates Executive’s employment for Cause, or upon Executive’s death or disability, then Executive will
no longer vest in any equity interests and all payments of compensation by the Company to Executive hereunder will terminate immediately
(except as to amounts already earned). The Company shall thereafter have no further obligations to Executive, except as may otherwise
be required by law.

 

5.5            Effect
of Termination. Executive agrees that should his employment be terminated for any reason,
he shall be deemed to have resigned from any and all positions, including any director and/or officer positions with the Company
and its affiliated entities, unless otherwise agreed to by the Company. Executive shall remain covered by all applicable insurance
policies, including Director and Officer insurance.

 

5.6            Section 409A
Compliance. It is intended that any benefits under this Agreement satisfy, to the greatest
extent possible, the exemptions from the application of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”),
provided under Treasury Regulations Sections 1.409A-1(b)(4), and 1.409A-1(b)(9), and this Agreement will be construed to the greatest
extent possible as consistent with those provisions, and to the extent not so exempt, this Agreement (and any definitions hereunder)
will be construed in a manner that complies with Section 409A. For purposes of Section 409A (including, without limitation,
for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments
under this Agreement (whether severance payments, if any, or otherwise) shall be treated as a right to receive a series of separate
payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment.
Severance benefits shall not commence until the Executive has a “separation from service” (as defined under Treasury
Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “separation from service”).
Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company at the time of termination
to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i), and if any of the payments set forth herein
are deemed to be “deferred compensation,” then to the extent delayed commencement of any portion of such payments
is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) and the related adverse taxation
under Section 409A, such payments shall not be provided prior to the earliest of (i) the expiration of the six-month
period measured from the date of termination, (ii) the date of Executive’s death or (iii) such earlier date as
permitted under Section 409A without the imposition of adverse taxation. Upon the first business day following the expiration
of such period, all payments deferred pursuant to this paragraph shall be paid in a lump sum, and any remaining payments due shall
be paid as otherwise provided herein. No interest shall be due on any amounts so deferred. Finally, if the period during which
Executive may consider and sign a release in connection with the receipt of severance benefits spans two calendar years, the payment
of severance will not be made or begin until the later calendar year.

 

     

     

    

 

5.7            Release.
As a condition precedent to receipt of the benefits set forth in Section 5.3 above
or Section 6 below, Executive shall furnish to the Company an executed waiver and release of claims in a form to be provided
by the Company, which shall include confidentiality, non-disclosure, and non-disparagement provisions, and may include an obligation
for Executive to provide reasonable transition assistance (the “Release”) within the time period specified
therein, but in no event later than forty-five days following Executive’s termination, unless otherwise provided by law.
Executive acknowledges and agrees that such transition services shall be fully compensated by the benefits described herein.

 

6.            Benefits
in Connection with Change In Control

 

6.1            Termination
of Employment in Connection with a Change in Control. If there is a Change in Control
(as defined below) and (i) Executive’s employment is terminated Without Cause (as defined below), or (ii) Executive
terminates his/her employment with Good Reason (as defined below), in each case within three (3) months prior to, or twelve
(12) months following, the effective date of the Change in Control, and provided a Release (as discussed in Section 5.7)
has become effective, then, in substitution for any benefits provided in Section 5.3, Executive shall be entitled to the
following benefits: (A) a lump sum payment equal to the sum of (y) eighteen (18) months of Executive’s then-current
annual Base Salary and (z) 150% of the current target Annual Bonus, to be made not later than 60 days following Executive’s
date of termination; and (B) the amount of any COBRA continuation premium payments made by Executive during the eighteen
(18) month period following the date of termination, or the period ending when Executive becomes eligible for comparable group
medical benefits from another source (whichever comes first). For avoidance of doubt, under no circumstances shall Executive receive
benefits under both this Section 6.1 and Section 5.2.

 

6.2            Acceleration
of Options; Change in Control. If the Company terminates Executive’s employment
with the Company without Cause, or Executive resigns for Good Reason, in either case within three (3) months prior to, or
twelve (12) months following the closing of a Change in Control (as defined below), then in addition to the benefits set forth
in Section 6.1 and pursuant to the terms of Section 5.7, the Company will fully accelerate the vesting of any equity
interests granted to Executive, such that 100% of the then-unvested shares subject to such equity interests will be deemed vested
as of Executive’s last day of employment, and Executive shall have up to ninety (90) days from Executive’s last day
of employment within which to exercise his vested options.

 

7.            Definitions

 

7.1            Cause.
For purposes of this Agreement, “Cause” shall mean the occurrence
of any of the following: (i) Executive’s conviction of any felony or any crime involving fraud or dishonesty; (ii) Executive’s
participation in fraud, act of dishonesty or act of gross misconduct against the Company and/or its Board that results in material
and demonstrably financial or reputational harm to the Company; or (iii) Executive’s material violation of any statutory
or fiduciary duty, or duty of loyalty, owed to the Company. Prior to a termination for Cause pursuant to (ii) or (iii) above,
to the extent such event(s) is capable of being cured by Executive, (A) the Company shall give Executive written notice
of such event(s), which notice shall specify in reasonable detail the circumstances constituting Cause, (B) Executive shall
have thirty (30) days after the delivery of such notice to cure the event(s) giving rise to Cause.

 

     

     

    

 

7.2            Good
Reason. For purposes of this Agreement, Executive shall have “Good Reason”
for resignation from employment with the Company if any of the following actions are taken by the Company without Executive’s
prior written consent: (a) a material reduction in Executive’s base salary, which the parties agree is a reduction
of at least 10% of Executive’s Base Salary, which has been mutually agreed to by Executive pursuant to a salary reduction
program; or (b) a material reduction in Executive’s duties (including responsibilities and/or authorities); or (c) relocation
of Executive’s principal place of employment to a place that increases Executive’s one-way commute by more than fifty
(50) miles as compared to Executive’s then-current principal place of employment immediately prior to such relocation. In
order to resign for Good Reason, Executive must provide written notice to the Board within 30 days after the first occurrence
of the event giving rise to Good Reason setting forth the basis for Executive’s resignation, allow the Company at least
30 days from receipt of such written notice to cure such event, and if such event is not reasonably cured within such period,
Executive must resign from all positions Executive then holds with the Company not later than 90 days after the expiration of
the cure period.

 

7.3            Change
in Control. For purposes of this Agreement, “Change in Control” is
defined in the Company’s 2018 Equity Incentive Plan.

 

8.            Parachute
Payments

 

8.1            Except
as otherwise provided in Section 8.2 below, if it is determined in accordance with Section 8.4  below that any
portion of the Payments (as defined in Section 8.5(b)) that otherwise would be paid or provided to the Executive or for his
benefit in connection with the 280G Change in Control would be subject to the excise tax imposed under section 4999 of the Code
(“Excise Tax”), then such Payments shall be reduced by the smallest amount necessary in order for no portion of the
Executive’s total Payments to be subject to the Excise Tax.

 

8.2            No
reduction in any of the Executive’s Payments shall be made pursuant to Section 8.1 above if the After Tax Amount of
the Payments payable to him without such reduction would exceed the After Tax Amount of the reduced Payments payable to him in
accordance with Section 8.1 above. For purposes of the foregoing, (i) the “After Tax Amount” of the Executive’s
Payments, as computed with, and as computed without, the reduction provided for under Section 8.1, shall mean the amount
of the Payments, as so computed, that the Executive would retain after payment of all taxes (including without limitation any
federal, state or local income taxes, the Excise Tax or any other excise taxes, any employment, social security or medicare taxes,
and any other taxes) imposed with respect to such Payments in the year or years in which payable; and (ii) the amount of
such taxes shall be computed at the rates in effect under the applicable tax laws in the year in which the 280G Change in Control
occurs, or if then ascertainable, the rates in effect in any later year in which any Payment is expected to be paid following
the 280G Change in Control (and if not so ascertainable, using then current rates), and in the case of any income taxes, by using
the maximum combined federal, state  and (if applicable) local income tax rates then in effect under such laws.

 

     

     

    

 

8.3            Any
reduction in the Executive’s Payments required to be made pursuant to Section 8.1 above (the “Required Reduction”)
shall be made as follows: first, any outstanding performance-based cash or equity incentive awards the performance periods for
which had not ended, and the performance goals for which had not been attained, prior to the occurrence of the 280G Change in
Control, to the extent such awards are treated as Payments as defined in Section 8.5(b) below, shall be reduced, by
cancellation of the acceleration of the vesting and time of payment of such awards; second, any severance payments or benefits,
or any other Payments the full amounts of which are treated as contingent on the 280G Change in Control pursuant to paragraph
(a) of Treas. Reg. §1.280G-l, Q/A 24 shall be reduced; and third, any cash or equity awards, or nonqualified deferred
compensation amounts, that vest solely based on the Executive’s continued service with the Company, and that pursuant to
paragraph (c) of Treas. Reg. § 1.280G-l, Q/A 24 are treated as contingent on the 280G Change in Control because they
become vested as a result of the 280G Change in Control, shall be reduced, by canceling the acceleration of their vesting. 
In each case, the amounts described in clauses first, second and third of the preceding sentence, (x) shall be reduced only
to the extent of the portion thereof, if any, that is treated as contingent on the 280G Change in Control under the regulations
issued under Code section 280G,  (y) shall be reduced in the inverse order of their originally scheduled dates of payments
or vesting, as applicable, and  (z) shall be so reduced only to the extent necessary to achieve the Required Reduction.
Notwithstanding the foregoing, if the Required Reduction would result in any portion of the Payment being subject to taxes pursuant
to Section 409A of the Code that would not otherwise be subject to taxes pursuant to Section 409A of the Code, then
the Reduced Reduction shall be modified so as to avoid the imposition of taxes pursuant to Section 409A of the Code as follows:
(A) as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic benefit for
Executive as determined on an after-tax basis; (B) as a second priority, Payments that are contingent on future events (e.g.,
being terminated without cause), shall be reduced (or eliminated) before Payments that are not contingent on future events; and
(C) as a third priority, Payments that are “deferred compensation” within the meaning of Section 409A of
the Code shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A
of the Code.

 

8.4            The
determinations made pursuant to this Section 8, and the assumptions to be utilized in arriving at such determinations, shall
be made by a nationally recognized accounting or consulting firm chosen by the Board or a committee thereof (the “280G Calculation
Firm”) at the expense of the Company. The 280G Calculation Firm shall take into account whether, and to what extent (if
any), such Payments or portions thereof may properly be treated as “reasonable compensation for personal services rendered”
by the Executive before, or after, the 280G Change in Control, within the meaning of Code section 280G(b)(4) and the regulations
issued thereunder, as well as any other appropriate provisions of Section 280G of the Code and the regulations thereunder
that may cause such Payments to appropriately be characterized as other than “parachute payments.” The 280G Calculation
Firm shall provide a written report of its determinations hereunder, including detailed supporting calculations, both to the Executive
and to the Company. The determinations made by the 280G Calculation Firm hereunder shall be binding upon the Executive and the
Company absent manifest error.

 

8.5            For
purposes of this Agreement, the following terms shall have the following respective meanings:

 

(a)            “280G
Change in  Control” shall mean a change in the ownership or effective control of the Company or in the ownership of
a substantial portion of the assets of Company, as determined in accordance with section 280G(b)(2) of the Code and the regulations
issued thereunder.

 

     

     

    

 

(b)            “Payment”
shall mean any payment or benefit in the nature of compensation that is to be paid or provided to the Executive or for her benefit
in connection with a 280G Change in Control (whether under this Agreement or otherwise, including by the entity, or by any affiliate
of the entity, whose acquisition of the stock or assets of  the Company or any of their affiliates constitutes the 
280G Change in Control), if the Executive is a “disqualified individual” (as defined in section 280G(c) of the
Code) at the time of the 280G Change in Control, to the extent that such payment or benefit is “contingent” on the
280G Change in Control within the meaning of section 280G(b)(2)(A)(i) of the Code and the regulations issued thereunder.

 

8.6            If
Executive receives a Payment for which a Required Reduction was made so that the Excise Tax did not apply to the Payment and the
Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Executive shall
promptly return to the Company a sufficient amount of the Payment (after reduction pursuant to Section 8.1this Agreement
so that no portion of the remaining Payment is subject to the Excise Tax; however, to the extent the Payment was made pursuant
to Section 8.2 above with no reduction to the Payment , Executive shall have no obligation to return any portion of the Payment
pursuant to the preceding sentence.

 

9.            Arbitration.
To ensure the timely and economical resolution of disputes that may arise in connection with Executive’s employment with
the Company, Executive and the Company agree that any and all disputes, claims, or causes of action arising from or relating to
the enforcement, breach, performance, negotiation, execution, or interpretation of this Agreement, the CIIAA, or Executive’s
employment, or the termination of Executive’s employment, including but not limited to all statutory claims, with the exception
of discrimination and harassment claims, will be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. §1-16 (the “FAA”),
and to the fullest extent permitted by law, by final, binding and confidential arbitration by a single arbitrator conducted in
New York, New York by Judicial Arbitration and Mediation Services Inc. (“JAMS”) under the then applicable
JAMS rules (at the following web address: https://www.jamsadr.com/rules-employment-arbitration/); provided, however,
this arbitration provision shall not apply to sexual harassment and discrimination claims to the extent prohibited by applicable
law that is not preempted by the FAA. A hard copy of the rules will be provided to Executive upon request. A hard copy of
the rules will be provided to Executive upon request. By agreeing to this arbitration procedure, both Executive and the
Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.  In addition,
all claims, disputes, or causes of action under this section, whether by Executive or the Company, must be brought in an individual
capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding,
nor joined or consolidated with the claims of any other person or entity. The Arbitrator may not consolidate the claims of more
than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding
sentences regarding class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any
claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. The Company
acknowledges that Executive will have the right to be represented by legal counsel at any arbitration proceeding. Questions of
whether a claim is subject to arbitration under this Agreement) shall be decided by a federal court in the State of New York.
However, procedural questions which grow out of the dispute and bear on the final disposition are matters for the arbitrator.
The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award
such relief as would otherwise be permitted by law; (b) issue a written arbitration decision, to include the arbitrator’s
essential findings and conclusions and a statement of the award; and (c) be authorized to award any or all remedies that
Executive or the Company would be entitled to seek in a court of law. The Company agrees to pay the costs and fees of the arbitration,
including the arbitrator’s fees. Each party shall pay their own attorneys’ fees and costs, except that in any action
to enforce any of the provisions of this Agreement or the the CIIAA, the prevailing party shall be entitled to recover its reasonable
attorney’s fees and costs, if not prohibited by applicable law, in addition to any other damages and remedies available
at law or in equity. Nothing in this Agreement is intended to prevent either Executive or the Company from obtaining injunctive
relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations
may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. To the extent applicable
law prohibits mandatory arbitration of sexual harassment or discrimination claims and is not preempted by the FAA, in the event
Executive intends to bring multiple claims, including a sexual harassment or discrimination claim, the sexual harassment and/or
discrimination claims may be publicly filed with a court, while any other claims will remain subject to mandatory arbitration.

 

     

     

    

 

10.          Indemnification
and Directors and Officers’ Insurance.

 

10.1          The
Indemnification Agreement between Incysus Therapeutics, Inc. (now the Company) and Executive, dated May 7, 2018, will
remain in effect following Executive’s separation from the Company for any reason.

 

11.          General
Provisions.

 

11.1          Representations
and Warranties. Executive represents and warrants that Executive is not restricted or
prohibited, contractually or otherwise, from entering into and performing each of the terms and covenants contained in this Agreement,
and that Executive’s execution and performance of this Agreement will not violate or breach any other agreements between
the Executive and any other person or entity.

 

11.2          Advertising
Waiver. Executive agrees to permit the Company, and persons or other organizations authorized
by the Company, to use, publish and distribute advertising or sales promotional literature concerning the products and/or services
of the Company in which Executive’s name and/or pictures of Executive appear. Executive hereby waives and releases any claim
or right Executive may otherwise have arising out of such use, publication or distribution.

 

11.3          D&O
Insurance. Executive shall be entitled to indemnification from the Company pursuant to,
and in accordance with the terms of, (i) the Company’s charter and bylaws, to the extent that indemnification of Executive
is provided for therein, and (ii) any D&O insurance policy covering Executive purchased by the Company.

 

11.4          Tax
Withholding. All payments and awards contemplated or made pursuant to this Agreement
will be subject to withholdings of applicable taxes in compliance with all relevant laws and regulations of all appropriate government
authorities. Executive acknowledges and agrees that the Company has neither made any assurances nor any guarantees concerning
the tax treatment of any payments or awards contemplated by or made pursuant to this Agreement. Executive has had the opportunity
to retain a tax and financial advisor and fully understands the tax and economic consequences of all payments and awards made
pursuant to the Agreement.

 

     

     

    

 

11.5          Miscellaneous.
This Agreement, along with the CIIAA, constitutes the complete, final and exclusive embodiment
of the entire agreement between Executive and the Company with regard to its subject matter. It is entered into without reliance
on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such
promises, warranties or representations, including, but not limited to the Prior Agreement (as amended) and the Prior CIIAA with
the exception of any stock or equity agreement between Executive and the Company. This Agreement may not be modified or amended
except in a writing signed by both Executive and a duly authorized member of the Board. This Agreement will bind the heirs, personal
representatives, successors and assigns of both Executive and the Company, and inure to the benefit of both Executive and the
Company, and to his and its heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable,
in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will
be modified so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and
enforced in accordance with the laws of the State of New York. Any ambiguity in this Agreement shall not be construed against
either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver
of any successive breach. This Agreement may be executed in counterparts and facsimile signatures will suffice as original signatures.

 

[Signature
Page Follows]

 

     

     

    

 

In
Witness Whereof, the parties have executed this Agreement as of the day and year first written above.

 

	 	IN8bio, Inc.

 

	 	 
	 	By:	/s/ Alan Roemer

	 	 	Name:	Alan Roemer
	 	 	Title:	 Chairman, Board of Directors

 

	Accepted and agreed:	 
	/s/ William
    Ho	 
	William Ho	 

 

     

     

    

 

Exhibit A

 

Permitted Non-Company Positions

 

		1.	Managing member of AlephPoint
                                         Capital Management and its related entities

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]